How Regulatory Support Fuels US Orphan Drugs Market Growth
  The landscape of the US orphan drugs market is rapidly transforming, with projections indicating a market size of approximately 53.59 billion USD in 2024, escalating to an extraordinary 139.43 billion USD by 2035. The driving force behind this robust growth is a combination of favorable regulatory frameworks and increased patient advocacy. With a compound annual growth rate (CAGR) of...
0 Comments 0 Shares 238 Views 0 Reviews